Table 2. Clinical Outcomes in All Patients and the ACS and SAP Groups.
All patients | ACS | SAP | |
---|---|---|---|
MACE, n (%) | 19 (11) | 7 (14) | 12 (10) |
MI, n (%) | 6 (3) | 3 (6) | 3 (3) |
TLR, n (%) | 18 (10) | 7 (14) | 11 (9) |
Death, n (%) | 1 (0.6) | 0 (0) | 1 (0.8) |
MACEs: major adverse cardiovascular events; MI: myocardial infarction; TLR: target lesion revascularization.